Overview
David invests in the life sciences, focusing on therapeutics, R&D tools, and biopharma infrastructure. He began his work at the Broad Institute on viral diagnostics (results published in Nature and Cell) and was co-founder and Head of Strategy & Ops of gene therapy company Latus Bio. He is a graduate of Harvard University.
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
David invests in the life sciences, focusing on therapeutics, R&D tools, and biopharma infrastructure. He began his work at the Broad Institute on viral diagnostics (results published in Nature and Cell) and was co-founder and Head of Strategy & Ops of gene therapy company Latus Bio. He is a graduate of Harvard University.